These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 10935251

  • 1. [The evidence for primary axonal loss in multiple sclerosis].
    Anthony DC, Hughes P, Perry VH.
    Rev Neurol; ; 30(12):1203-8. PubMed ID: 10935251
    [Abstract] [Full Text] [Related]

  • 2. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J.
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [Abstract] [Full Text] [Related]

  • 3. Sodium channel expression within chronic multiple sclerosis plaques.
    Black JA, Newcombe J, Trapp BD, Waxman SG.
    J Neuropathol Exp Neurol; 2007 Sep; 66(9):828-37. PubMed ID: 17805013
    [Abstract] [Full Text] [Related]

  • 4. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
    Wolswijk G, Balesar R.
    Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
    [Abstract] [Full Text] [Related]

  • 5. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
    Witte ME, Bø L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, van der Valk P, van Horssen J.
    J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of axonal and neuronal damage in multiple sclerosis.
    Dutta R, Trapp BD.
    Neurology; 2007 May 29; 68(22 Suppl 3):S22-31; discussion S43-54. PubMed ID: 17548565
    [Abstract] [Full Text] [Related]

  • 7. Pathological findings in rats with experimental allergic encephalomyelitis.
    Dong M, Liu R, Guo L, Li C, Tan G.
    APMIS; 2008 Nov 29; 116(11):972-84. PubMed ID: 19132994
    [Abstract] [Full Text] [Related]

  • 8. [Axonal damage in multiple sclerosis].
    Arbizu-Urdiain T, Martínez-Yélamos A.
    Rev Neurol; 2008 Nov 29; 30(12):1223-7. PubMed ID: 10935255
    [Abstract] [Full Text] [Related]

  • 9. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006 Nov 29; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 10. Different patterns of axonal damage after intracerebral injection of malonate or AMPA.
    Cuthill DJ, Fowler JH, McCulloch J, Dewar D.
    Exp Neurol; 2006 Aug 29; 200(2):509-20. PubMed ID: 16698016
    [Abstract] [Full Text] [Related]

  • 11. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord.
    DeBoy CA, Zhang J, Dike S, Shats I, Jones M, Reich DS, Mori S, Nguyen T, Rothstein B, Miller RH, Griffin JT, Kerr DA, Calabresi PA.
    Brain; 2007 Aug 29; 130(Pt 8):2199-210. PubMed ID: 17557778
    [Abstract] [Full Text] [Related]

  • 12. Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis.
    Teunissen CE, Dijkstra CD, Jasperse B, Barkhof F, Vanderstichele H, Vanmechelen E, Polman CH, Bö L.
    Neuropathol Appl Neurobiol; 2006 Jun 29; 32(3):318-31. PubMed ID: 16640650
    [Abstract] [Full Text] [Related]

  • 13. Evidence of axonal damage in human acute demyelinating diseases.
    Ghosh N, DeLuca GC, Esiri MM.
    J Neurol Sci; 2004 Jul 15; 222(1-2):29-34. PubMed ID: 15240192
    [Abstract] [Full Text] [Related]

  • 14. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis.
    Geurts JJ, Wolswijk G, Bö L, van der Valk P, Polman CH, Troost D, Aronica E.
    Brain; 2003 Aug 15; 126(Pt 8):1755-66. PubMed ID: 12805104
    [Abstract] [Full Text] [Related]

  • 15. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 15; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions.
    van Horssen J, Vos CM, Admiraal L, van Haastert ES, Montagne L, van der Valk P, de Vries HE.
    Neuropathol Appl Neurobiol; 2006 Dec 15; 32(6):585-93. PubMed ID: 17083473
    [Abstract] [Full Text] [Related]

  • 17. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
    Fisher E, Chang A, Fox RJ, Tkach JA, Svarovsky T, Nakamura K, Rudick RA, Trapp BD.
    Ann Neurol; 2007 Sep 15; 62(3):219-28. PubMed ID: 17427920
    [Abstract] [Full Text] [Related]

  • 18. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H.
    J Neurosci Res; 2008 Dec 15; 86(16):3548-55. PubMed ID: 18709652
    [Abstract] [Full Text] [Related]

  • 19. Inflammation and degeneration in multiple sclerosis.
    Brück W, Stadelmann C.
    Neurol Sci; 2003 Dec 15; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [Abstract] [Full Text] [Related]

  • 20. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE, Nichols PP, Bates D, Turnbull DM.
    Med Hypotheses; 2005 Dec 15; 64(4):669-77. PubMed ID: 15694681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.